CLX benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.
Clorox Chair and CEO Linda Rendle joins 'Closing Bell Overtime' to talk quarterly results, consumer trends, and more.
Clorox Chair and CEO Linda Rendle joins 'Closing Bell Overtime' to talk quarterly results, consumer trends, and more.
Clorox's Q1 results reflect a recovery from last year's cyberattack-related woes. Organic sales across all segments and margin expansion boost its performance.
The Clorox Company (NYSE:CLX ) Q1 2025 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Lisah Burhan - Vice President, Investor Relations Linda Rendle - Chair and CEO Kevin Jacobsen - Chief Financial Officer Conference Call Participants Dara Mohsenian - Morgan Stanley Peter Grom - UBS Filippo Falorni - Citi Andrea Teixeira - JP Morgan Anna Lizzul - Bank of America Bonnie Herzog - Goldman Sachs Robert Moskow - TD Cowen Olivia Tong - Raymond James Kaumil Gajrawala - Jefferies Lauren Lieberman - Barclays Chris Carey - Wells Fargo Javier Escalante - Evercore ISI Steve Powers - Deutsche Bank Kevin Grundy - BNP Paribas Operator Good day, ladies and gentlemen. And welcome to The Clorox Company Quarterly and Fiscal Year Earnings Release Conference Call.
The headline numbers for Clorox (CLX) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Clorox (CLX) came out with quarterly earnings of $1.86 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $0.49 per share a year ago.
Besides Wall Street's top -and-bottom-line estimates for Clorox (CLX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.
CLX's first-quarter fiscal 2025 results are likely to gain from pricing and cost-saving efforts. It aims at innovation and brand building.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.